Formulation: A neat solid

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Pronitazene

Formulation: A solution in acetonitrile

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Etonitazepyne

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Protonitazepine
• Protonitazepyne

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• NIH 7607

Formulation: A solid

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Butoxynitazene

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Desnitroetonitazene
• Etazene
• Etazone

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Isotonitazepine
• Isotonitazepyne

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 2-fluoro Desethoxyetonitazene
• 4’-fluoro Nitazene

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Metonitazepyne

Formulation: A 1 mg/ml solution in methanol

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• Etonitazepipne
• N-Piperidyl Etonitazene

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

• 3'-desoxy-3',4'-Methylenedioxynitazene
• Tetrahydrofuranitazene

Formulation: A crystalline solid

Purity: ≥98%

Schedule: I

Formulation: A 1 mg/ml solution in methanol

Purity: ≥98%

• Pronitazene

Formulation: A solid

Purity: ≥98%

Schedule: I

• 5-methyl Desnitroetonitazene
• 5-methyl Etazene
• 5-methyl Etazone
• Etomethazene

Formulation: A crystalline solid

Purity: ≥98%

• O-desalkyl Isotonitazene

Formulation: A solution in acetonitrile

Purity: ≥98%

• ​5-Amino Isotodesnitazene

Formulation: A crystalline solid

Purity: ≥98%

• Desnitroisotonitazene

Formulation: A solid

Purity: ≥98%